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To precisely define the incidence, type and consequences of
cardiac arrhythmias early after heart transplantation, 25
cardiac transplant recipients were monitored continuously
for 728 days from the day of surgery to discharge or death.
Asubset of 15 patients had sinus node function studies with
overdrive suppression performed weekly at the time of
endomyocardial biopsy.
Results revealed sinus bradycardia in 10 patients (40%)
and junctional bradycardia in 6 (24%). Supraventricular
tachycardia in the form of atrial tachycardia, atrial fibril-
lation and atrial flutter occurred in 11 patients (44%).
Ventricular tachycardia occurred in 15 patients (60%) and
was nonsustained in all. Cardiac pacing for 1,403 h was
used in nine patients with a pulse rate <50 beats/min; seven
recovered and permanent pacing was instituted in two. In
Cardiac arrhythmias are frequent early after heart transplan-
tation. Studies conducted before the cyclosporine era (1-3)
analyzed daily electrocardiograms (ECG) to determine the
frequency and type of arrhythmia. Another study (4) in-
cluded the results of 24 h Holter monitoring recorded just
before hospital discharge. However, the precise incidence
may be underestimated by these studies. Moreover, the
introduction of cyclosporine may have a substantial effect on
arrhythmias by reducing the ensuing inflammatory response
(5-7).
To define more precisely the incidence of arrhythmias in
the early post-transplant period, we prospectively followed
up 25 transplant recipients by continuous telemetric record-
ing from the day of surgery until their discharge or death.
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the subgroup that had sinus node function studies, seven
patients were identified with clinical bradyarrhythmia;
each had abnormal sinus node recovery time (>1,400 ms)
and abnormal corrected sinus node recovery time (>525
ms) in at least one study. These seven patients also had a
significantly prolonged ischemic time (236 ± 26 versus 159
± 68 min, p < 0.01).
In conclusion, cardiac arrhythmias, particularly ven·
tricular tachycardia and bradyarrhythmia, occur more
commonly early after orthotopic heart transplantation than
has previously been reported. Sinus node dysfunction due
to prolonged organ ischemic time, antiarrhythmic drug use
or surgical trauma, alone or in combination, may contrib-
ute to these arrhythmias.
(J Am Coil CardioI1990;16:832-7)
From the results of previous studies (8-11) and our clinical
experience, we suspected that many episodes might be
related to sinus node dysfunction.
Methods
Study patients (Table 1). Twenty-five consecutive patients
undergoing orthotopic heart transplantation at the University
of Pittsburgh between November 1988 and May 1989 were
included. Characteristics of these patients are presented in
Table I. The indication for transplantation included ischemic
cardiomyopathy (n = 13), idiopathic cardiomyopathy (n = 9),
status postmyocarditis (n = I), hypertrophic cardiomyopathy
(n = 1) and Adriamycin (doxorubicin hydrochloride)-induced
cardiomyopathy (n = I). Standard crystalloid cardioplegia was
perfused in the donor's heart before removal, and the heart was
transported in Stanford solution. Graft ischemic time ranged
from 75 to 273 min. Graft implantation was performed with the
Stanford technique (12). Immunosuppressive treatment includ-
ing cyclosporine A, azathioprine and steroids was given to all
patients.
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As part of routine post-transplant care. the patients were
followed up by telemetric monitoring until their discharge or
death. A strip recording of every arrhythmia detected by the
charge nurse at the central monitoring station was preserved
for later assessment. The time of onset and end of each
episode was carefully noted. The central monitoring station
is equipped with an arrhythmia detection program and every
recognized arrhythmic event was stored in the station mem-
ory. The memory was cleared every 4 h and all arrhythmias
not previously detected were recorded on strip paper. Rec-
ords were reviewed daily and correlated with clinical symp-
toms and laboratory data.
Sinus node studies. In a subgroup of 15 patients. atrial
wires were placed on the right atrium during surgery. With
the patient's informed consent. sinus node recovery time
was assessed at weekly intervals at the time of endomyocar-
dial biopsy. Sinus node recovery time was measured after
overdrive suppression at a maximal pacing rate of ISO/min
for 60 s (13,14). The stimulus strength was twice the thresh-
old value, with a pulse width of I ms. Corrected sinus node
recovery time was calculated by subtracting the preceding
spontaneous cycle length from the recovery time.
Definition of acute rejection. A rejection episode was
defined as a 7 day period. starting 3 days before and ending
3 days after the day of a biopsy. showing myocyte necrosis
(grade 3 in the classification of Billingham [15]). Arrhythmia
incidence during rejection episodes was compared with the
incidence in patients without rejection.
Definition of arrhythmias. Sinus tachycardia was defined
as a sinus node discharge> 100 beats/min and sinus brady-
cardia as a sinus node discharge <60 beats/min. Ajunctional
rhythm >60 beats/min was classified as junctional tachycar-
dia. Junctional escape rhythm (rate 35 to 60 beats/min) and
junctional bradycardia were analyzed together because the
latter arrhythmia was very rare and always associated with
an escape rhythm. Supraventricular tachyarrhythmia was
defined as ectopic atrial tachycardia with a narrow QRS
complex or atrial flutter or atrial fibrillation. Ventricula:
arrhythmia included episodes of ventricular tachycardia (>4
Table 1. Characteristics of 25 Transplant Patients
Men
Women
Age (yrl
Follow-up duration (days)
Ischemic time (min)
Inotropic support (days)
Infection (no.)
Rejection (no.)
Potassium minimum (mEq/liter)
Magnesium minimum (mEq/liter)
Died (no.)
Donor age (yr)
Data are mean values ± SD.
21
4
48.8 ± 12.8
28.8 ± 9.8
190.1 ± 67
4.9 ± 3
7
8
3.2 ± OJ
1.3 ± 0.2
3
3003 ± 7.6
beats; rate> 100 beats/min), and accelerated idioventricular
rhythm (rate 40 to 100 beats/min). Sustained ventricular
tachycardia was defined as runs of>30 s. (In this study, the
identification of nonsustained ventricular tachycardia with-
out the use of electrophysiologic testing was based on the
fact that none of the patients had bundle branch block. All
episodes started with multiple ventricular premature beats.)
Premature atrial and ventricular beats were not rated accord-
ing to their frequency, but only by their presence or absence
during a single day. External ventricular pacing was used in
patients with symptomatic bradycardia or when the sponta-
neous rate decreased to <50 beats/min. The rate was usually
set at 50 beats/min and increased to 60 beats/min if necessary
for symptom relief.
Statistical data analysis. Data are expressed as the mean
value ± I SD. Variables were analyzed using Fisher's exact
test. For the rest of the analysis. independent Student's t test
was used (alpha = 0.05, beta = 0.10).
Results
Antiarrhythmic drug use. Five recipients received anti-
arrhythmic medications, including lidocaine in four patients.
and three patients received combinations of digoxin, vera-
pamil and procainamide to treat supraventricular tachyar-
rhythmia. Three patients died during the study period. None
of these deaths was related to an arrhythmia.
Prevalence of arrhythmia during the entire follow-up pe-
riod (Tables 2 to 4). Arrhythmias occurring in the 25 patients
during the entire follow-up period of 728 monitored days are
summarized in Tables 2 and 3. The most frequent were
premature beats, both atrial (occurring in 76% of the patients
but on only 15% of the follow-up days) and ventricular
(occurring in all but one patient during 50% of the follow-up
days). Short runs of nonsustained ventricular tachycardia
(67 runs) and accelerated idioventricular rhythm were re-
corded in 60% of the patients. These 67 runs were spread
over 44 days (6% of the follow-up days) and lasted for <30 s.
These episodes were treated with intravenous lidocaine only
when they occurred during the first postoperative 48 h (four
patients were treated). None of the later episodes required
specific treatment and none was fatal.
Supraventricular arrhythmias occurred in 11 patients
(44%). Most episodes were short « I min) and two patients
accounted for 65 h of the total episode duration of 68.81 h.
One of those two patients had two episodes of severe
rejection; the supraventricular arrhythmia in these two pa-
tients was atrial flutter. The remaining nine patients had
atrial tachycardia. atrial fibrillation or atrial flutter for a very
short period. Three patients were treated with digoxin.
verapamil and procainamide. Two of them had previously
required temporary pacing for symptomatic bradycardia
(Fig. I). They have alternating tachybradyarrhythmia typical
of sick sinus syndrome; this condition necessitated implan-
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Table 2. Incidence of Arrhythmias in 25 Transplant Recipients Over the Entire Follow-Up Period
Group I Group II Group III
Days With at Least I Total Duration in
Affected Patients Episode Hours
Type of Arrhythmia No. % No. % No. %
Sinus tachycardia II 44 17 2J 65.1 OJ
Sinus bradycardia 10 40 59 8.1 361.6 2.0
Junctional tachycardia 8 32 23 3.0 377.1 2.1
Junctional escape or 6 24 38 5.2 265.8 1.7
bradycardia, or both
SV tachyarrhythmia* II 44 45 6.1 68.8 0.4
V tachyarrhythmiat 15 60 44 6.0 <0.1 <0.1
Premature A beats 19 76 109 IS
Premature V beats 24 96 357 49
Paced rhythm 9 36 113 15 1,403 8.0
*SV tachyarrhythmia = supraventricular tachycardia (including atrial fibrillation and flutter); tV tachyarrhythmia
= ventricular tachyarrhythmia (including ventricular tachycardia and accelerated idioventricular rhythm). Total
duration is not reported for premature beats because of the difficulty in recording this variable. A = atrial; V =
ventricular.
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Table 3. Supraventricular Tachyarrhythmias in 11 Patients
tation of a permanent pacemaker for persistent bradycardia
within 4 weeks of surgery. At the time of permanent pacing,
no circulating level ofantiarrhythmic drug was detectable. In
the third patient (the patient with rejection), atrial flutter was
first recorded and maintained and he continued to receive
treatment until discharge.
functional tachycardia was also frequent, occurring in
eight patients (32%). Five of eight patients with junctional
tachycardia during the early postoperative days developed
sinus bradycardia or junctional escape rhythm, or both, later
on. The incidence of arrhythmia during the first 7 days
compared with the entire follow-up period is summarized in
Table 4.
Bradyarrhythmia affected fewer patients but was the
longest lasting arrhythmia. Sinus bradycardia, junctional
escape rhythm or symptomatic bradycardia treated with a
standby pacemaker occurred in 10 patients. Atrial or ven-
tricular pacing at a rate of <50 beats/min was necessary in
nine patients (36%) for a total of 1,403 h (8% of the total
follow-up hours), but only two patients (8%) received a
permanent pacemaker (Fig. 2). Comparing the 10 patients
with bradyarrhythmia with the remaining 15 patients, a
significant difference was observed for the graft ischemic
time (236 ± 29 versus 159 ± 68 min, p < 0.01).
Atrial tachycardia alone
Atrial flutter alone
Atrial tachycardia/fibrillation/flutter
Total no. of patients
No. of Affected
Patients
7
n
II
Total Duration
(h)
2.02
66.79
68.81
Arrhythmia during rejection. The incidence of arrhyth-
mia during episodes of transplant rejection was compared
with that in patients without rejection during the same mean
follow-up period per patient (7 days). No difference was
observed in the incidence of arrhythmia between the two
groups except for ventricular tachycardia. Seven of 8 pa-
tients with rejection had ventricular tachycardia (nonsus-
tained) compared with 8 of 17 without rejection (p < 0.05).
Sinus node function tests (Tables 5 and 6). The subgroup
of 15 patients whose sinus node function was assessed by
overdrive suppression was classified according to the pres-
ence or absence of clinical bradycardia (including sinus
bradycardia, junctional escape rhythm, junctional bradycar-
dia and need for pacing) (Fig. 3). All eight patients without
bradycardia had normal values for sinus node recovery time
and corrected sinus node recovery time in the three studies.
Table 4. Incidence of Arrhythmia in 25 Patients, Comparing the
First 7 Days Postoperatively (early) With the Entire Follow-Up
Period (late)
No. of Affected Patients
Type of Arrhythmia Early Late Total
Sinus tachycardia II 0 II
Sinus bradycardia 9 I 10
Junctional tachycardia 7 I 8
Junctional bradycardia 5 I 6
Supraventricular tachycardia 3 8 II
Ventricular tachycardia 9 6 15
Premature atrial beats 7 12 19
Premature ventricular beats 20 4 24
Pacing 9 0 9
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CSNRT
P=O.038
SNRT
P=O.027
Figure 3. Results of sinus node function studies at week 2 and
comparison between Group I (hatched bars) (n = 8) and Group II
(solid bars) (n = 7). CSNRT = corrected sinus node recovery time;
SCL = spontaneous cycle length; SNRT = sinus node recovery
time.
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Table 5. Characteristics of the 10 Patients With Bradycardia and
the 15 Patients Without Bradycardia
the first and second studies but recovered normal function
by week 3; both of these patients were discharged without
additional treatment. The fifth patient with an abnormal
sinus node response had a slightly prolonged sinus recovery
time (1,460 ms) and corrected sinus node recovery time (530
ms) at week 3 but was still receiving treatment with procain-
amide as a possible explanation for the persistence of mildly
depressed sinus node function. This patient was discharged
on low doses of procainamide and had an acceptable heart
rate.
No difference was noted between patients with normal
and abnormal sinus node function tests except for organ
ischemic time, which was significantly longer for patients
with abnormal sinus node function (236 ± 26 versus 159 ± 68
min, p < 0.01).
The mean left I'entricular ejection fraction for the entire
group was 63 ± 8% (range 45% to 77%). The ejection
fraction for patients with ventricular tachycardia was 63.5 ±
Figure 1. Rhythm strips from a patient with episodes of sinus
rhythm and premature ventricular beats (A), paroxysmal atrial
fibrillation (B), paced rhythm alternating with atrial tachycardia (e),
runs of nonsustained ventricular tachycardia (D) and extreme brady-
cardia before permanent pacemaker implantation (E).
No significant difference was found among the three study
intervals (Table 6).
Sinus node recovery time and corrected sinus node
recovery time were significantly longer for the seven pa-
tients with clinical bradycardia at each time interval
(Table 6). In this group, a trend toward a decrease in sinus
node recovery time and corrected sinus node recovery
time was noted from week 1 to week 3, although the
difference did not reach statistical significance. Of these
seven patients, five had an abnormal sinus node recovery
time (> 1,400 ms) and corrected sinus node recovery time
(>525 ms) in at least one study. Two patients had a sinus
node recovery time >3,000 ms in each of the studies. Both
patients were treated with procainamide, verapamil and
digoxin for supraventricular arrhythmia but were free of
antiarrhythmic drugs at the time of the last study; both
patients underwent implantation of a permanent pacemaker
before hospital discharge.
Two other patients had abnormal sinus node function in No. With
Bradycardia
No.
Without
Bradycardia
*p < 0.05. Bradycardia includes sinus bradycardia. junctional escape
rhythm. junctional bradycardia and atrial and ventricular pacing at <60
beats/min. Data represent mean values:!: SO.
Figure 2. Electrocardiographic recording from one of the two pa-
tients who received permanent pacing. There is extreme sinus
bradycardia of the donor (0). Also notice recipient (R) heart with
sinus node activity at a rate of 100 beats/min.
R D
~ l~~ ~~
No.
Men
Women
Age (yr)
Donor age (yr)
Ischemic time (min)
Acute rejection
Inotropic support (days)
10
9
J
51.2:!: 10
30.6:!: 14
236 :!: 29'
3/10
4.4 :!: 1.2
15
12
3
47.3 :!: 10.1
28 :!: 7.1
159:!: 68
5/15
5.8 :!: 4.5
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Table 6. Results of Sinus Node Function Tests in 15 Patients
All data are in milliseconds :!: I SD. CSNRT = corrected sinus node
recovery time: SCL = spontaneous cycle length: SNRT = sinus node
recovery time; W = week.
8% and was not significantly different from that of patients
without ventricular tachycardia (62.6 ± 9%, p = 0.88). The
ejection fraction in patients who exhibited supraventricular
tachycardia was not different from that of patients without
this arrhythmia (61.3 ± 7% versus 64.7 ± 9%, p = 0.2).
Patients who exhibited bradyarrhythmia had an ejection
fraction of 62 ± 8% versus 64 ± 9% for those without
bradyarrhythmia (p = 0.444).
Discussion
Our data demonstrate that many types of arrhythmia are
common early after cardiac transplantation. For the majority
of arrhythmias, we observed a higher overall incidence than
that reported by others (1-3), a finding that we believe is the
result of a more complete assessment by continuous tele-
metric monitoring than previously used. This method also
allowed us to define more precisely the clinical importance
of the observed rhythm abnormalities by precise quantifica-
tion of their duration. Premature ventricular depolarizations,
nonsustained ventricular tachycardia and accelerated idio-
ventricular rhythm were frequently recorded, with prema-
ture ventricular depolarizations occurring in all but one
patient. However, these arrhythmias were always self-
limited and never had clinical consequences.
Ventricular arrhythmias. A high incidence of premature
ventricular beats and ventricular tachycardia has been re-
ported (1,2) in the early post-transplant period. Supersensi-
tization of the denervated heart to circulating catechol-
amines has been suggested as a possible pathogenic
mechanism (16). Prolonged organ ischemia and perhaps
reperfusion injury and excessive manipulation of the donor
heart are possible mechanisms suggested by a higher prev-
alence in the transplant recipients. No difference in graft
ischemic time was noted among patients with or without
ventricular arrhythmia. Significantly more patients with than
without recorded ventricular tachycardia had rejection (7 of
15 versus I of 10, respectively). To minimize possible errors
in estimating the duration of rejection, we chose to define a
rejection episode as a 7 day period around positive biopsy
findings and to compare the prevalence of arrhythmia during
this period with the prevalence in patients who had no
rejection episode. The presence of myocyte necrosis has
been accepted (17) as a necessary criterion to increase
immunosuppressive treatment, but possible deleterious ef-
fects and particularly arrhythmogenic effects could occur
with less severe rejection. In the absence of a better measure
of rejection, any conclusion based on association with ar-
rhythmias must be cautious.
Supraventricular arrhythmias. Premature atrial beats and
supraventricular arrhythmias including atrial tachycardia,
flutter and fibrillation were less frequent than were ventric-
ular arrhythmias and were recorded more often during the
late follow-up period than during the first 2 postoperative
weeks. The role of sympathetic innervation in the origin of
these arrhythmias is further suggested by the comparison
with patients undergoing coronary bypass surgery: su-
praventricular arrhythmias have been noted more frequently
after coronary bypass surgery in patients receiving preoper-
ative propranolol therapy that is discontinued after surgery
(18).
Sinus tachycardia and junctional tachycardia. These were
recorded almost exclusively during the Ist postoperative
week when patients were receiving exogenous catechol-
amines. The occurrence of sinus tachycardia during this
period is generally but not always indicative of a good
preservation of the sinus node; 3 of II patients later devel-
oped evidence of sinus node dysfunction. Conversely, junc-
tional tachycardia was more frequently associated later with
bradyarrhythmias (five of eight patients). Increased sensitiv-
ity of the atrioventricular (AVj node to exogenous catechol-
amines associated with moderate and rapidly reversible
sinus node depression might explain the presence of junc-
tional tachycardia without later evidence of sinus node
Injury.
Role of immunosuppressive therapy. A recent report (19)
compared the prevalence of arrhythmias after orthotopic
cardiac transplantation between cyclosporine- and azathio-
prine-tested groups. Patients treated with cyclosporine had
statistically significantly fewer arrhythmias than did those
treated with azathioprine. All of our patients received both
cyclosporine and azathioprine. In addition, some also re-
ceived rabbit antithymocyte globulin. The prevalence of
arrhythmia in our study group was similar to that reported by
Little et al. (19) in patients who received cyclosporine in the
immediate post-transplant period.
Bradyarrhythmias and sinus node function. Bradyar-
rhythmias were recorded more often than reported in previ-
ous studies (20) and analysis of their duration demonstrates
their clinical significance: > 10% of the total follow-up period
was characterized by bradyarrhythmias. Moreover, 36% of
NS
0.03
NS
0.020
0.027
NS
NS
0.038
NS
p Value
Group II:
Bradycardia
(n = 7)
830 :!: 125
881 :!: 171
795 :!: 109
2,036 :!: 1,001
1,976 :!: 366
1,145 :t 231
516 :t 579
407 :t 125
350 :t 178
718 :!: 93
706 :!: 69
744 :!: 113
948 :!: 192
912:!: 141
958 :!: 169
230 :!: 106
206 :!: 107
214 :!: 97
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No Bradycardia
(n = 8)
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the patients required temporary pacing support. No evi-
dence of second or higher degree AV block was recorded.
The majority of these bradyarrhythmias, defined as a
heart rate <60 beats/min or a paced rate <50 beats/min, are
thus related to some degree of sinus node dysfunction,
especially since spontaneous cycle length of denervated
hearts is expected to be <800 ms (rate of 75 beats/min)
(21,22). Studies (23) in long-term survivors have demon-
strated a higher reliability of suppression tests in the
denervated heart than in the general population. All patients
who did not exhibit clinical bradycardia had a normal and
stable sinus node recovery time, whereas five of seven
patients with bradycardia had at least one abnormal mea-
surement. Thus, the test may not be sensitive enough to
detect minor dysfunction, which was clinically manifested in
two patients.
Possible mechanisms ofsinus node injury after transplan-
tation include direct injury during surgery or ischemia, or
both. The only difference we found between patients with
an abnormal sinus node function test and patients with
normal results was a prolonged organ ischemic time before
transplantation. Likewise, patients with clinical bradycardia
had a longer ischemic time than did transplant recipients
without bradyarrhythmia. Because we accepted donor
hearts with longer ischemic periods, this could also explain
the higher prevalence of bradycardia than previously re-
ported.
Evidence ofsinus node dysfunction regresses over time in
most patients. The majority of the bradyarrhythmic episodes
were recorded during the 2nd postoperative week. Results of
the overdrive suppression test seem to improve from week
to week in patients with an initially abnormal test. However,
two patients had an abnormal function test by week 3 and
subsequently required implantation of a permanent pace-
maker. Electrophysiologic studies are planned in these pa-
tients to see whether delayed recuperation of a normal sinus
node function occurs. In contrast to the only study of
bradyarrhythmias in the early post-transplant periods (8),
sinus node dysfunction was not associated with a poor
prognosis in our group of patients.
Conclusions. The most clinically significant arrhythmias
occurring after heart transplantation are related to various
degrees of sinus node dysfunction. A prolonged organ ische-
mic time before transplantation seems to be the primary
factor contributing to this dysfunction. Sinus node dysfunc-
tion is transitory in most patients but sometimes persists for
>3 weeks after surgery. Ventricular arrhythmias and prema-
ture beats are the most common arrhythmias and a possible
association with an immunologic phenomenon is not com-
pletely ruled out, especially because a strong correlation
exists with rejection episodes.
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